Narco Unicote Finishing Cement

Product Description

Narco Unicote Finishing Cement was a refractory finishing cement manufactured by North American Refractories Company (NARCO), a major producer of high-temperature industrial materials throughout much of the twentieth century. Finishing cements of this type were engineered specifically for application over refractory linings in furnaces, kilns, boilers, and other high-heat industrial equipment. They were used to seal, smooth, and protect the surfaces of refractory installations, providing a dense, hard-wearing outer layer that resisted thermal cycling, mechanical abrasion, and chemical attack under extreme operating conditions.

NARCO was among the most prominent refractory manufacturers in the United States, supplying products to steel mills, foundries, glass plants, petrochemical facilities, power generation stations, and a wide range of other heavy industries. Unicote Finishing Cement was part of NARCO’s broader line of castable and monolithic refractory products, which were marketed to industries requiring reliable, long-lasting linings capable of withstanding temperatures that conventional construction materials could not endure. The cement was typically supplied in dry powder or pre-mixed form and was troweled, gunned, or hand-applied directly to refractory surfaces during construction, repair, and maintenance operations.

Products in this category were sold widely across American industry during the decades when asbestos-containing refractory formulations were considered standard practice. NARCO, like many refractory manufacturers of the era, incorporated asbestos into numerous products because of the mineral’s well-documented resistance to heat and its ability to reinforce the structural integrity of high-temperature materials.

Asbestos Content

Narco Unicote Finishing Cement contained asbestos as a functional component of its refractory formulation. Asbestos fibers — most commonly chrysotile, and in some refractory products amphibole varieties such as amosite — were blended into finishing cements to enhance thermal stability, tensile strength, and resistance to cracking under rapid temperature changes. In refractory applications, asbestos provided a fibrous matrix that helped bind the cement together and resist spalling during the repeated heating and cooling cycles characteristic of industrial furnace operations.

Documentation associated with NARCO’s product lines, including materials relevant to the North American Refractories Company Asbestos PI Trust, confirms that asbestos-containing products were manufactured and sold by the company over an extended period. Finishing cements were among the product categories that incorporated asbestos as a deliberate ingredient. The presence of asbestos in these materials was not incidental — it was considered an engineering advantage at a time when the health hazards of asbestos exposure were not adequately communicated to the workers who handled these products.

How Workers Were Exposed

Industrial workers who handled, mixed, applied, or worked in proximity to Narco Unicote Finishing Cement faced potential asbestos fiber exposure across several distinct phases of product use.

Mixing and Preparation: When dry finishing cement was measured and mixed — whether by hand or using mechanical mixers — airborne asbestos dust was generated. Workers who opened bags, poured powdered cement, or stirred mixing batches in enclosed or poorly ventilated areas could inhale significant quantities of respirable asbestos fibers during these preparatory steps.

Application: Troweling and hand-applying finishing cement to furnace walls, arch sections, and refractory surfaces brought workers into direct and sustained contact with the material. During application, the mechanical working of the cement could release asbestos fibers into the breathing zone of workers performing this task, as well as nearby coworkers operating in the same area.

Cutting and Finishing: After the applied cement cured, workers sometimes ground, chipped, or cut the hardened surface to achieve desired tolerances or to remove imperfections. Dry cutting and grinding of cured asbestos-containing refractory cement is recognized as a high-dust-generating activity capable of releasing substantial concentrations of airborne fibers.

Furnace Repair and Demolition: Scheduled maintenance shutdowns at industrial facilities routinely required the removal of old refractory linings before new material could be installed. Workers who broke out deteriorated finishing cement, chipped away hardened refractory surfaces, or worked in confined furnace interiors during relining operations were exposed to friable, dust-generating debris that could contain significant asbestos concentrations.

Bystander Exposure: Workers who were not directly handling Narco Unicote Finishing Cement but were present on the same job site — including workers in adjacent trades such as boilermakers, pipefitters, ironworkers, and maintenance personnel — could also inhale asbestos dust generated by nearby mixing and application activities.

Industrial settings such as steel mills, foundries, coke ovens, glass manufacturing plants, and petrochemical refineries represented the primary environments where NARCO finishing cements were used. Workers in these industries generally performed repeated exposure over the course of careers spanning many years, increasing the cumulative dose of asbestos fibers they received. Chronic exposure of this kind has been associated in occupational health literature and legal proceedings with the development of serious asbestos-related diseases, including mesothelioma, asbestosis, lung cancer, and pleural disease.

NARCO filed for bankruptcy protection as a result of the substantial volume of asbestos-related personal injury claims filed against the company. As part of that bankruptcy resolution, the North American Refractories Company Asbestos PI Trust was established to compensate individuals who developed asbestos-related diseases as a result of exposure to NARCO products, including Narco Unicote Finishing Cement.

Trust Fund Eligibility

Individuals who were exposed to Narco Unicote Finishing Cement manufactured by North American Refractories Company and who subsequently developed a qualifying asbestos-related disease may be eligible to file a claim with the North American Refractories Company Asbestos PI Trust. The trust was created specifically to address claims arising from NARCO’s asbestos-containing refractory products.

Typical qualifying disease categories recognized by asbestos PI trusts of this type include:

  • Mesothelioma (pleural, peritoneal, or pericardial)
  • Lung cancer with documented asbestos exposure
  • Asbestosis confirmed by pulmonary function testing or pathological findings
  • Other asbestos-related pleural disease, including pleural plaques, pleural thickening, and diffuse pleural disease meeting defined medical criteria

Claimants are generally required to demonstrate product exposure — showing that they worked with or in proximity to Narco Unicote Finishing Cement specifically, or other NARCO products — along with a qualifying medical diagnosis. Exposure documentation may include employment records, co-worker affidavits, union records, or work history statements supported by other evidence.

How to Pursue a Claim

Individuals diagnosed with mesothelioma or another asbestos-related illness after exposure to Narco Unicote Finishing Cement, as well as the surviving family members of individuals who have died from such diseases, should consult with an attorney experienced in asbestos trust fund claims. Legal counsel can evaluate the specific exposure history, identify all applicable trusts and litigation options, and assist with assembling the documentation needed to support a claim submission to the North American Refractories Company Asbestos PI Trust.

Trust fund claims are separate from civil litigation, and in many cases individuals may have claims against multiple trusts or defendants based on their full occupational history. A thorough review of work history often reveals exposures to products from more than one manufacturer, potentially qualifying claimants for compensation from several sources simultaneously.